Jeffrey Breall

Title

Professor of Clinical Medicine

Department

Department of Medicine

Institution

Indiana University System

jbreall@iu.edu

Education

Research and Clinical Fellow in Cardiology Harvard Medical School and Beth Israel Hospital, Boston, MA 2000
Regents Fellow in Physiology University of California, San Francisco
2000
Research Fellow, Coronary Research Laboratory Albert Einstein College of Medicine 2000
Senior Assistant Resident, Internal Medicine Beth Israel Hospital, Boston, MA 2000
Intern in Medicine Beth Israel Hospital, Boston, MA 2000
Junior Assistant Resident, Internal Medicine: Beth Israel Hospital, Boston, MA 2000
Cardiovascular Research Training Grant Harvard Medical School and Beth Israel Hospital 2000
Medicine (M.D.) 1987
Physiology, Human and Animal California, University Of (San 1983
Physiology, Human and Animal California, University Of (Ber 1978
Cardiovascular Research Training Grant Harvard Medical School and Beth Israel Hospital 1905 PubMed

Research Interests

Coronary Artery Disease C Reactive Protein Hypertrophic Obstructive Cardiomyopathy Quality Assurance

View all research interests

Biography

Dr. Breall received his undergraduate degree in physiology from the University of California at Berkeley and his PhD in physiology at the University of California at San Francisco, where he worked in the laboratory of Dr. Abraham M. Rudolph in the Cardiovascular Research Institute. Dr. Breall earned his MD degree at the Albert Einstein College of Medicine. He also spent several months in the coronary laboratory of Dr. Edward Kirk. Breall completed his residency and fellowship research training in cardiovascular diseases and interventional cardiology at Beth Israel Hospital and Harvard Medical School in Boston. Dr. Breall was on the faculty at Georgetown University for seven years where he served as Associate Director of the Cardiac Catheterization Laboratories and Interventional Cardiology. He came to Indiana University in 2000 to lead the interventional section. He has participated in numerous multi-center clinical trials, and has authored many papers and book chapters. Dr. Breall specializes in high-risk coronary intervention. He is the Director of the Cardiac Catheterization Laboratories and head of Interventional Cardiology for Indiana University and Medical Director of the Cardiac Catheterization Laboratories for Clarian Health Partners. He has had a long-standing interest in new devices and new pharmacologic agents for percutaneous coronary and cardiac intervention, as well as quality improvement in the catheterization laboratory. Breall is a member of the Councils on Clinical Cardiology Cardiovascular Radiology and Intervention and Fellow of the American Heart Association, the American College of Cardiology, American College of Chest Physicians, and American College of Physicians.

Homepages

Contact Information

Not mentioned yet.

Research

Not mentioned yet.

Cloud List

Coronary Artery Disease C Reactive Protein Hypertrophic Obstructive Cardiomyopathy Quality Assurance Cardiac Catheterization Laboratory Interventional Cardiology Platelet Aggregation Clinical Pharmacology Blood Coagulation Successful Use Non Cardiac Surgery Cardiac Events Case Report Sudden Cardiac Death Heart Institute Cardiac Angiography Cardiovascular Interventions Cocaine Use Increased Incidence Texas Children Percutaneous Intervention Cardiovascular Patients Clinical Review

List of Publications (19)

In 2014

Factor XIII Val34Leu polymorphism and recurrent myocardial infarction in patients with coronary artery disease.
Found on Publication Page

SINC or swim (should we intervene in non-culprit vessels during STEMI?).
Found on Publication Page

In 2013

Cytochrome P450 3A4*22, PPAR-alpha, and ARNT polymorphisms and clopidogrel response.
Found on Publication Page

C-reactive protein and fibrin clot strength measured by thrombelastography after coronary stenting.
Found on Publication Page

In 2012

A comparison of the use of traditional hand injection versus automated contrast injectors during cardiac catheterization.
Found on Publication Page

Protease activated receptor-1 (PAR-1) mediated platelet aggregation is dependent on clopidogrel response.
Found on Publication Page

Influence of paraoxonase-1 Q192R and cytochrome P450 2C19 polymorphisms on clopidogrel response.
Found on Publication Page

In 2011

Successful use of the Impella device in giant cell myocarditis as a bridge to permanent left ventricular mechanical support.
Found on Publication Page

Cardiac events after non-cardiac surgery in patients with previous coronary intervention in the drug-eluting stent era.
Found on Publication Page

In 2010

Percutaneous alcohol septal ablation following surgical myectomy.
Found on Publication Page

Impact of proton pump inhibitors on the effectiveness of clopidogrel after coronary stent placement: the clopidogrel Medco outcomes study.
Found on Publication Page

In 2009

Sudden cardiac death complicating alcohol septal ablation: a case report and review of literature.
Found on Publication Page

In 2008

Alcohol septal ablation for hypertrophic obstructive cardiomyopathy.
Found on Publication Page

In 2007

Increased incidence of stent thrombosis in patients with cocaine use.
Found on Publication Page

In 2005

Percutaneous intervention through a Cabrol composite graft.
Found on Publication Page

In 2004

Approach to "aspirin allergy" in cardiovascular patients.
Found on Publication Page

In 2003

Complete situs inversus and bicuspid aortic valve stenosis.
Found on Publication Page

In 2002

Myocardial Bridge: a clinical review.
Found on Publication Page

Distal emboli protection in patients undergoing percutaneous coronary intervention after a recent myocardial infarction.
Found on Publication Page

Search Profiles

Colleagues

Yael Massen

Indiana University System

Jeniffer Sams

Indiana University System

Asok Antony

Indiana University System

View All Colleagues